“…Sharavii et al studied all candidate genes related to the development of ESS in humans and divided them into four groups: Group 1-genes, related to the development of ESS (the most significant are the PRL gene coding for prolactin, the GH1 gene coding for growth hormone, the POMC gene coding for proopiomelanocortin, the TRH gene coding for thyrotropin releasing hormone, the IGF1 gene coding for insulin like growth factor 1); Group 2-candidate genes related to pathways of ESS (TRH, PRL, POMC, NPY, GNRH1, GH1 genes coding for peptide-ligand building receptors); Group 3-candidate genes related to cellular components of ESS (PRL, POMC, NPY, IGFBP3, IGF1); Group 4-candidate genes related to biological processes of ESS (TRH, POMC, NPY, INS, GNRH1) which participate in the regulation of biological processes associated with the G protein-coupled receptors signaling pathway. 2 Only a few cases of familial ESS are described in the literature. White et al reported a case of three sisters, born of a consanguineous marriage.…”